Antibody responses to group A streptococcal infections in acute rheumatic fever

Pediatric Infectious Disease Journal

Volumn 25, Issue 9, 2006, Pages 832-837

  Martins, Thomas B ^a   Veasy, L George ^a,b   Hill, Harry R ^a,b  

^a ARUP INSTITUTE FOR CLINICAL AND EXPERIMENTAL PATHOLOGY   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Acute rheumatic fever; Antibody responses; Cross reactivity; Group A streptococcus; Molecular mimicry

Indexed keywords

BACTERIAL ANTIGEN; CARBOHYDRATE; COLLAGEN TYPE 1; COLLAGEN TYPE 4; CROSS REACTING ANTIGEN; GANGLIOSIDE; M PROTEIN;

ANTIBODY RESPONSE; HUMAN; IMMUNE RESPONSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; TAXONOMY;

EID: 33748324640     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.inf.0000232634.55883.d0     Document Type: Article

References (59)

1. Cairns LM. The immunology of rheumatic fever. N Z Med J. 1988;101:388-391.
2. Bisno AL, Brito MO, Collins CM. Molecular basis of group A streptococcal virulence. Lancet Infect Dis. 2003;3:191-200.
3. Bisno AL. Group A streptococcal infections and acute rheumatic fever. N Engl J Med. 1991;325:783-793.
4. Alsaeid K, Majeed HA. Acute rheumatic fever: diagnosis and treatment. Pediatr Ann. 1998;27:295-300.
5. Gibofsky A, Khanna A, Suh E, Zabriskie JB. The genetics of rheumatic fever: relationship to streptococcal infection and autoimmune disease. J Rheumatol Suppl. 1991;30:1-5.
6. Veasy LG, Tani LY, Hill HR. Persistence of acute rheumatic fever in the intermountain area of the United States. J Pediatr. 1994;124:9-16.
7. Veasy LG, Tani LY, Daly JA, et al. Temporal association of the appearance of mucoid strains of Streptococcus pyogenes with a continuing high incidence of rheumatic fever in Utah. Pediatrics. 2004;113:e168-172.
8. Bisno AL. The resurgence of acute rheumatic fever in the United States. Annu Rev Med. 1990;41:319-329.
9. Congeni BL. The resurgence of acute rheumatic fever in the United States. Pediatr Ann. 1992;21:816-820.
10. Veasy LG, Wiedmeier SE, Orsmond GS, et al. Resurgence of acute rheumatic fever in the intermountain area of the United States. N Engl J Med. 1987;316:421-427.
11. Gibofsky A, Zabriskie JB. Rheumatic fever and poststreptococcal reactive arthritis. Curr Opin Rheumatol. 1995;7:299-305.
12. Veasy LG, Hill HR. Immunologic and clinical correlations in rheumatic fever and rheumatic heart disease. Pediatr Infect Dis J. 1997;16:400-407.
13. Roberts S, Kosanke S, Terrence Dunn S, Jankelow D, Duran CM, Cunningham MW. Pathogenic mechanisms in rheumatic carditis: focus on valvular endothelium. J Infect Dis. 2001;183:507-511.
14. Wald ER. Acute rheumatic fever. Curr Probl Pediatr. 1993;23:264-270.
15. Church AJ, Dale RC, Cardoso F, et al. CSF and serum immune parameters in Sydenham's chorea: evidence of an autoimmune syndrome? J Neuroimmunol. 2003;136:149-153.
16. Church AJ, Cardoso F, Dale RC, Lees AJ, Thompson EJ, Giovannoni G. Anti-basal ganglia antibodies in acute and persistent Sydenham's chorea. Neurology. 2002;59:227-231.
17. Cardoso F. Chorea: non-genetic causes. Curr Opin Neurol. 2004;17:433-436.
18. Poynton FJ, Paine A. The etiology of rheumatic fever. Lancet. 1900;2:861-869.
19. Vashishtha A, Fischetti VA. Surface-exposed conserved region of the streptococcal M protein induces antibodies cross-reactive with denatured forms of myosin. J Immunol. 1993;150:4693-4701.
20. Friedman J, van de Rijn I, Ohkuni H, Fischetti VA, Zabriskie JB. Immunological studies of post-streptococcal sequelae: evidence for presence of streptococcal antigens in circulating immune complexes. J Clin Invest. 1984;74:1027-1034.
21. Cunningham MW. Cardiac myosin and the TH1/TH2 paradigm in autoimmune myocarditis. Am J Pathol. 2001;159:5-12.
22. Khanna AK, Nomura Y, Fischetti VA, Zabriskie JB. Antibodies in the sera of acute rheumatic fever patients bind to human cardiac tropomyosin. J Autoimmun. 1997;10:99-106.
23. Kirvan CA, Swedo SE, Heuser JS, Cunningham MW. Mimicry and autoantibody-mediated neuronal cell signaling in Sydenham chorea. Nat Med. 2003;9:914-920.
24. Quinn A, Kosanke S, Fischetti VA, Factor SM, Cunningham MW. Induction of autoimmune valvular heart disease by recombinant streptococcal m protein. Infect Immun. 2001;69:4072-4078.
25. Bronze MS, Dale JB. Epitopes of streptococcal M proteins that evoke antibodies that cross-react with human brain. J Immunol. 1993;151:2820-2828.
26. Dinkla K, Rohde M, Jansen WT, Kaplan EL, Chhatwal GS, Talay SR. Rheumatic fever-associated Streptococcus pyogenes isolates aggregate collagen. J Clin Invest. 2003;111:1905-1912.
27. El-Demellawy M, El-Ridi R, Guirguis NI, Abdel Alim M, Kotby A, Kotb M. Preferential recognition of human myocardial antigens by T lymphocytes from rheumatic heart disease patients. Infect Immun. 1997;65:2197-2205.
28. Jones KF, Whitehead SS, Cunningham MW, Fischetti VA. Reactivity of rheumatic fever and scarlet fever patients' sera with group A streptococcal M protein, cardiac myosin, and cardiac tropomyosin: a retrospective study. Infect Immun. 2000;68:7132-7136.
29. Lymbury RS, Olive C, Powell KA, et al. Induction of autoimmune valvulitis in Lewis rats following immunization with peptides from the conserved region of group A streptococcal M protein. J Autoimmun. 2003;20:211-217.
30. Quinn A, Ward K, Fischetti VA, Hemric M, Cunningham MW. Immunological relationship between the class I epitope of streptococcal M protein and myosin. Infect Immun. 1998;66:4418-4424.
31. Dale JB, Washburn RG, Marques MB, Wessels MR. Hyaluronate capsule and surface M protein in resistance to opsonization of group A streptococci. Infect Immun. 1996;64:1495-1501.
32. Todome Y, Ohkuni H, Yokomuro K, et al. Enzyme-linked immunosorbent assay of antibody to group A streptococcus-specific C carbohydrate with trypsin-pronase-treated whole cells as antigen. J Clin Microbiol. 1988;26:464-470.
33. Shet A, Kaplan EL. Clinical use and interpretation of group A streptococcal antibody tests: a practical approach for the pediatrician or primary care physician. Pediatr Infect Dis J. 2002;21:420-426.
34. Kaplan EL, Ferrieri P, Wannamaker LW. Comparison of the antibody response to streptococcal cellular and extracellular antigens in acute pharyngitis. J Pediatr. 1974;84:21-28.
35. Cleary PP, Prahbu U, Dale JB, Wexler DE, Handley J. Streptococcal C5a peptidase is a highly specific endopeptidase. Infect Immun. 1992;60:5219-5223.
36. Ji Y, McLandsborough L, Kondagunta A, Cleary PP. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect Immun. 1996;64:503-510.
37. Wexler DE, Chenoweth DE, Cleary PP. Mechanism of action of the group A streptococcal C5a inactivator. Proc Natl Acad Sci U S A. 1985;82:8144-8148.
38. Shet A, Kaplan EL, Johnson DR, Cleary PP. Immune response to group A streptococcal C5a peptidase in children: implications for vaccine development. J Infect Dis. 2003;188:809-817.
39. Shet A, Kaplan E, Johnson D, Cleary PP. Human immunogenicity studies on group A streptococcal C5a peptidase (SCPA) as a potential vaccine against group A streptococcal infections. Indian J Med Res. 2004;119(suppl):95-98.
40. O'Connor SP, Darip D, Fraley K, Nelson CM, Kaplan EL, Cleary PP. The human antibody response to streptococcal C5a peptidase. J Infect Dis. 1991;163:109-116.
41. Ji Y, Carlson B, Kondagunta A, Cleary PP. Intranasal immunization with C5a peptidase prevents nasopharyngeal colonization of mice by the group A streptococcus. Infect Immun. 1997;65:2080-2087.
42. Lancefield RC. Persistence of type-specific antibodies in man following infection with group A streptococci. J Exp Med. 1959;110:271-292.
43. Jones KF, Manjula BN, Johnston KH, Hollingshead SK, Scott JR, Fischetti VA. Location of variable and conserved epitopes among the multiple serotypes of streptococcal M protein. J Exp Med. 1985;161:623-628.
44. Jones KF, Khan SA, Erickson BW, Hollingshead SK, Scott JR, Fischetti VA. Immunochemical localization and amino acid sequences of cross-reactive epitopes within the group A streptococcal M6 protein. J Exp Med. 1986;164:1226-1238.
45. Batzloff M, Yan H, Davies M, Hartas J, Good M. Preclinical evaluation of a vaccine based on conserved region of M protein that prevents group A streptococcal infection. Indian J Med Res. 2004;119(suppl):104-107.
46. Bessen D, Fischetti VA. Synthetic peptide vaccine against mucosal colonization by group A streptococci, I: protection against a heterologous M serotype with shared C repeat region epitopes. J Immunol. 1990;145:1251-1256.
47. Mannam P, Jones KF, Geller BL. Mucosal vaccine made from live, recombinant Lactococcus lactis protects mice against pharyngeal infection with Streptococcus pyogenes. Infect Immun. 2004;72:3444-3450.
48. Bessen DE, Veasy LG, Hill HR, Augustine NH, Fischetti VA. Serologic evidence for a class I group A streptococcal infection among rheumatic fever patients. J Infect Dis. 1995;172:1608-1611.
49. Brandt ER, Hayman WA, Currie B, et al. Opsonic human antibodies from an endemic population specific for a conserved epitope on the M protein of group A streptococci. Immunology. 1996;89:331-337.
50. Brandt ER, Hayman WA, Currie B, et al. Functional analysis of IgA antibodies specific for a conserved epitope within the M protein of group A streptococci from Australian Aboriginal endemic communities. Int Immunol. 1999;11:569-576.
51. Dudding BA, Ayoub EM. Persistence of streptococcal group A antibody in patients with rheumatic valvular disease. J Exp Med. 1968;128:1081-1098.
52. Schmidt WC, Moore DJ. The determination of antibody to group A streptococcal polysaccharide in human sera by hemagglutination. J Exp Med. 1965;121:793-806.
53. Salvadori LG, Blake MS, McCarty M, Tai JY, Zabriskie JB. Group A streptococcus-liposome ELISA antibody titers to group A polysaccharide and opsonophagocytic capabilities of the antibodies. J Infect Dis. 1995;171:593-600.
54. Kaplan MH. Autoantibodies to heart and rheumatic fever: the induction of autoimmunity to heart by streptococcal antigen cross-reactive with heart. Ann N Y Acad Sci. 1965;124:904-915.
55. Kaplan MH. Induction of autoimmunity to heart in rheumatic fever by streptococcal antigen(S) cross-reactive with heart. Fed Proc. 1965;24:109-112.
56. Zabriskie JB, Freimer EH. An immunological relationship between the group A streptococcus and mammalian muscle. J Exp Med. 1966;124:661-678.
57. Cunningham MW, Krisher K, Graves DC. Murine monoclonal antibodies reactive with human heart and group A streptococcal membrane antigens. Infect Immun. 1984;46:34-41.
58. Cunningham MW, Hall NK, Krisher KK, Spanier AM. A study of anti-group A streptococcal monoclonal antibodies cross-reactive with myosin. J Immunol. 1986;136:293-298.
59. Fischetti VA: streptococcal M protein. Sci Am. 1991;264:58-65.